T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
RadNet
RDNT
$6.06B
| $193M | 0.02% |
2,699,082
+627,936
| +30% | +$48.5M |
|
477
Colliers International
CIGI
$5.15B
| $192M | 0.02% |
1,308,985
+187,663
| +17% | +$28.2M |
|
478
KE Holdings
BEKE
$19.2B
| $192M | 0.02% |
12,177,783
-1,434,563
| -11% | -$24.6M |
|
479
Kanzhun
BZ
$7.19B
| $192M | 0.02% |
9,416,759
+1,213,240
| +15% | +$26.2M |
|
480
Cognex
CGNX
$10.2B
| $191M | 0.02% |
5,314,896
+1,258,629
| +31% | +$50.9M |
|
481
Eaton
ETN
$179B
| $189M | 0.02% |
592,783
+4,552
| +0.8% | +$1.61M |
|
482
NVR
NVR
$16.8B
| $189M | 0.02% |
25,882
-77
| -0.3% | -$576K |
|
483
Dycom Industries
DY
$12.3B
| $189M | 0.02% |
558,519
+110,065
| +25% | +$34.7M |
|
484
Martin Marietta Materials
MLM
$32.7B
| $189M | 0.02% |
303,031
+214,270
| +241% | +$133M |
|
485
Fair Isaac
FICO
$22.6B
| $189M | 0.02% |
111,558
-57,313
| -34% | -$98.7M |
|
486
CAVA Group
CAVA
$8.11B
| $186M | 0.02% |
3,175,413
-582,749
| -16% | -$32.5M |
|
487
FirstCash
FCFS
$9.28B
| $186M | 0.02% |
1,169,281
+312,132
| +36% | +$49.2M |
|
488
ResMed
RMD
$32.8B
| $186M | 0.02% |
770,414
-1,773
| -0.2% | -$453K |
|
489
Veeva Systems
VEEV
$39.2B
| $185M | 0.02% |
830,114
-396,438
| -32% | -$105M |
|
490
American Homes 4 Rent
AMH
$12.2B
| $185M | 0.02% |
5,751,148
-970,293
| -14% | -$31.1M |
|
491
Lumentum
LITE
$82.6B
| $184M | 0.02% |
499,612
+199,726
| +67% | +$51.3M |
|
|
SMA
492
SmartStop Self Storage REIT
SMA
$1.87B
| $183M | 0.02% |
5,913,679
+710,871
| +14% | +$24.1M |
|
493
Madrigal Pharmaceuticals
MDGL
$12.4B
| $183M | 0.02% |
313,659
-38,861
| -11% | -$19.8M |
|
494
Edwards Lifesciences
EW
$53.6B
| $181M | 0.02% |
2,126,755
+1,267,918
| +148% | +$104M |
|
495
Madison Square Garden
MSGS
$9.97B
| $181M | 0.02% |
699,378
+282,318
| +68% | +$64.3M |
|
496
East-West Bancorp
EWBC
$18.5B
| $181M | 0.02% |
1,607,314
+1,185,781
| +281% | +$126M |
|
497
IonQ
IONQ
$18.3B
| $180M | 0.02% |
4,009,931
+762,585
| +23% | +$42.7M |
|
|
SOBO
498
South Bow Corp
SOBO
$7.64B
| $177M | 0.02% |
6,456,032
-2,676,370
| -29% | -$72.7M |
|
499
Invesco
IVZ
$13.9B
| $177M | 0.02% |
6,729,393
+5,292,867
| +368% | +$129M |
|
|
AXON
500
Axon Enterprise
AXON
$48.7B
| $177M | 0.02% |
311,166
-10,966
| -3% | -$6.8M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.